Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2385939
Max Phase: Preclinical
Molecular Formula: C23H20N2O5
Molecular Weight: 404.42
Molecule Type: Small molecule
Associated Items:
ID: ALA2385939
Max Phase: Preclinical
Molecular Formula: C23H20N2O5
Molecular Weight: 404.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2cccc3cccc(c23)C(=O)N1CCNCCOc1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C23H20N2O5/c26-22-17-5-1-3-15-4-2-6-18(21(15)17)23(27)25(22)11-9-24-10-12-28-16-7-8-19-20(13-16)30-14-29-19/h1-8,13,24H,9-12,14H2
Standard InChI Key: ZTAWLVLQHQPJCS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 404.42 | Molecular Weight (Monoisotopic): 404.1372 | AlogP: 2.83 | #Rotatable Bonds: 7 |
Polar Surface Area: 77.10 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.82 | CX LogP: 2.81 | CX LogD: 1.38 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.48 | Np Likeness Score: -0.64 |
1. Guo P, Chen Q, Liu T, Xu L, Yang Q, Qian X.. (2013) Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase., 4 (6): [PMID:24900704] [10.1021/ml300475m] |
Source(1):